Institutional Ownership
Abbvie Inc
CUSIP 00287Y109COMABBVQ1 2026
Latest EPS (Diluted)
$0.39
Q1 2026 · Mar 31, 2026
Latest Revenue
$15.00B
Reported quarter
Latest Net Income
$695.00M
Reported quarter
Quarters on Record
12
From SEC XBRL filings
Quarterly Earnings
EPS, revenue & net income · SEC XBRL (10-Q / 10-K)
| Period | Quarter | EPS (Basic) | EPS (Diluted) | Revenue | Net Income | Form |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 2026 | $0.39 | $0.39 | $15.00B | $695.00M | 10-Q |
| Dec 31, 2025 | Q4 2025 | $1.02 | $1.02 | $16.62B | $1.82B | 10-K |
| Sep 30, 2025 | Q3 2025 | $0.10 | $0.10 | $15.78B | $186.00M | 10-Q |
| Jun 30, 2025 | Q2 2025 | $0.52 | $0.52 | $15.42B | $938.00M | 10-Q |
| Mar 31, 2025 | Q1 2025 | $0.72 | $0.72 | $13.34B | $1.29B | 10-Q |
| Dec 31, 2024 | Q4 2024 | $-0.02 | $-0.02 | $15.10B | -$22.00M | 10-K |
| Sep 30, 2024 | Q3 2024 | $0.88 | $0.88 | $14.46B | $1.56B | 10-Q |
| Jun 30, 2024 | Q2 2024 | $0.77 | $0.77 | $14.46B | $1.37B | 10-Q |
| Mar 31, 2024 | Q1 2024 | $0.77 | $0.77 | $12.31B | $1.37B | 10-Q |
| Dec 31, 2023 | Q4 2023 | $0.46 | $0.46 | $14.30B | $822.00M | 10-K |
| Sep 30, 2023 | Q3 2023 | $1.00 | $1.00 | $13.93B | $1.78B | 10-Q |
| Jun 30, 2023 | Q2 2023 | $1.14 | $1.14 | $13.87B | $2.02B | 10-Q |